Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 202386
Company: CHARTWELL MOLECULAR

Products on ANDA 202386

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
RISPERIDONE	RISPERIDONE	1MG/ML	SOLUTION;ORAL	Prescription	AA	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 202386

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/12/2015	ORIG-1	Approval				Label is not available on this site.

Therapeutic Equivalents for ANDA 202386

RISPERIDONE

SOLUTION;ORAL; 1MG/ML
TE Code = AA

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
RISPERDAL	RISPERIDONE	1MG/ML	SOLUTION;ORAL	Prescription	Yes	AA	020588	JANSSEN PHARMS
RISPERIDONE	RISPERIDONE	1MG/ML	SOLUTION;ORAL	Prescription	No	AA	091384	AMNEAL PHARMS
RISPERIDONE	RISPERIDONE	1MG/ML	SOLUTION;ORAL	Prescription	No	AA	078452	AUROBINDO PHARMA LTD
RISPERIDONE	RISPERIDONE	1MG/ML	SOLUTION;ORAL	Prescription	No	AA	202386	CHARTWELL MOLECULAR
RISPERIDONE	RISPERIDONE	1MG/ML	SOLUTION;ORAL	Prescription	No	AA	079158	LANNETT CO INC
RISPERIDONE	RISPERIDONE	1MG/ML	SOLUTION;ORAL	Prescription	No	AA	090347	TARO
RISPERIDONE	RISPERIDONE	1MG/ML	SOLUTION;ORAL	Prescription	No	AA	079059	TRIS PHARMA INC